MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia
2020 · Cell stem cell · 64 citations
https://doi.org/10.1016/j.stem.2020.09.004
J
Jessica Filiatrault
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
155
Citations
7
h-index
6
i10-index
Jessica Filiatrault is an academic researcher. The author has contributed to research in topics: Cancer-related Molecular Pathways & Acute Myeloid Leukemia Research & DNA Repair Mechanisms. The author has an h-index of 7, co-authored 20 publications.
ORCID: 0000-0002-1875-4949Papers by this author
worksInhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia
2020 · Experimental Hematology · 23 citations
https://doi.org/10.1016/j.exphem.2020.11.002
TGFβ pathway is required for viable gestation of Fanconi anemia embryos
2022 · PLoS Genetics · 16 citations
https://doi.org/10.1371/journal.pgen.1010459
KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
2024 · Molecular Cancer Therapeutics · 15 citations
https://doi.org/10.1158/1535-7163.mct-24-0306
Isolation of human and murine hematopoietic stem cells for DNA damage and DNA repair assays
2021 · STAR Protocols · 2 citations
https://doi.org/10.1016/j.xpro.2021.100846
Supplemental Figure 2 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
2025 · 0 citations
https://doi.org/10.1158/1535-7163.28713654
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat